Background stories of how others approached and experienced their European Horizon funding trajectory.
Published on | 7 months ago
Programmes HealthThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for detailsAutoship is, as the name suggests, an acronym for autonomous ship. Just like with self-driving cars, the possibilities of an unmanned boat seem endless. It can create more efficient freight transport, around the clock deliveries and these are just a few of the examples. The project has two societal challenges.
At first, De Vlaamse Waterweg was a bit hesitant as their experience with FP7 or Horizon 2020 projects was limited and they had not been very successful up until then. The fact that they were already doing basic research on the topic of autonomous boats, and the administrative help of NCP FLanders helped De Vlaamse waterweg to cross the line and get involved.